Eric L. Reyner
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 8
-
- Receptor Mechanisms and Signaling 2
- Co-authors
- Barbra H. Stewart (7 shared papers)O. Helen Chan (3 shared papers)Caroline A. Lee (3 shared papers)Elke Lipka (2 shared papers)Jeff B. Smaill (2 shared papers)Joseph A. Loo (2 shared papers)H. D. Hollis Showalter (2 shared papers)William A. Denny (2 shared papers)
- Journals
- Drug Metabolism and Disposition (3 papers)Journal of Medicinal Chemistry (3 papers)Genomics (2 papers)The Journal of Clinical Pharmacology (2 papers)Pharmaceutical Research (2 papers)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Eric L. Reyner
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Oncology 500
- Pharmacology 164
- Pharmaceutical Science 89
- Pediatrics, Perinatology and Child Health 167
- Organic Chemistry 234
Countries citing papers authored by Eric L. Reyner
This map shows the geographic impact of Eric L. Reyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Reyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Reyner more than expected).
Fields of papers citing papers by Eric L. Reyner
This network shows the impact of papers produced by Eric L. Reyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Reyner. The network helps show where Eric L. Reyner may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric L. Reyner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 237 | |
| 2 | 2011 | 198 | |
| 3 | 1995 | 165 | |
| 4 | 2000 | 146 | |
| 5 | 1997 | 84 | |
| 6 | 2010 | 63 | |
| 7 | 2011 | 61 | |
| 8 | 2010 | 41 | |
| 9 | 2013 | 33 | |
| 10 | Localization of DNA sequences to a region within Xp11.21 between incontinentia pigmenti (IP1) X-chromosomal translocation breakpoints. | 1991 | 30 |
| 11 | 1995 | 27 | |
| 12 | 2000 | 25 | |
| 13 | 2019 | 20 | |
| 14 | 2002 | 20 | |
| 15 | 1992 | 16 | |
| 16 | 2000 | 13 | |
| 17 | 1996 | 9 | |
| 18 | 1992 | 8 | |
| 19 | 2004 | 6 | |
| 20 | 1996 | 6 |
About Eric L. Reyner
Eric L. Reyner is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Nitric Oxide and Endothelin Effects (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Genetic and rare skin diseases. (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Quinazolinone synthesis and applications (2 papers), HIV/AIDS drug development and treatment (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Oncology (500 citations), Pharmacology (164 citations), Pharmaceutical Science (89 citations), Pediatrics, Perinatology and Child Health (167 citations) and Organic Chemistry (234 citations). Eric L. Reyner has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Barbra H. Stewart, O. Helen Chan, Caroline A. Lee, Elke Lipka, Jeff B. Smaill, Joseph A. Loo, H. D. Hollis Showalter, William A. Denny, William L. Elliott and Kenneth D. Greis. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Medicinal Chemistry, Genomics, The Journal of Clinical Pharmacology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.